Volatile metabolites differentiate air–liquid interface cultures after infection with <i>Staphylococcus aureus</i>-Reference-Cited by-同舟云学术

Volatile metabolites differentiate air–liquid interface cultures after infection with Staphylococcus aureus

Published:2023 Issue:3 Volume:148 Page:618-627
ISSN:0003-2654
Container-title:The Analyst
language:en
Short-container-title:Analyst

Author:

Ahmed Waqar¹^ORCID,Bardin Emmanuelle²³,Davis Michael D.⁴,Sermet-Gaudelus Isabelle²⁵,Grassin Delyle Stanislas³⁶^ORCID,Fowler Stephen J.¹⁷^ORCID

Affiliation:

1. Division of Immunology, Immunity to infection & Respiratory Medicine, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, UK

2. Institut Necker-Enfants Malades, Paris, France

3. Université Paris-Saclay, UVSQ, INSERM, Infection et inflammation, Montigny le Bretonneux, France

4. Herman B Wells Center for Pediatric Research, Pediatric Pulmonology, Allergy, and Sleep Medicine, Indiana University School of Medicine, Indianapolis, USA

5. Service de Pneumo-Pédiatrie, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France

6. Hôpital Foch, Exhalomics, Département des maladies des voies respiratoires, Suresnes, France

7. NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Education and Research Centre, W ythenshawe Hospital, Manchester, M23 9LT, UK

Abstract

Thin film microextraction to sample VOCs from the apical side of an air–liquid interface culture model. After S. aureus infection, infected and uninfected cultures were distinguished using an untargeted metabolomics approach.

Publisher

Royal Society of Chemistry (RSC)

Subject

Electrochemistry,Spectroscopy,Environmental Chemistry,Biochemistry,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/AN/D2AN01205G

Reference36 articles.

1. Sustained Coinfections with Staphylococcus aureus and Pseudomonas aeruginosa in Cystic Fibrosis

2. International Study of the Prevalence and Outcomes of Infection in Intensive Care Units

3. Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study

4. The challenge of antimicrobial prescribing for hospital-acquired pneumonia

5. Exhaled Volatile Organic Compounds of Infection: A Systematic Review

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exhaled volatile organic compounds and respiratory disease: Recent progress and future outlook;TrAC Trends in Analytical Chemistry;2024-07

2. In vitro modelling of bacterial pneumonia: a comparative analysis of widely applied complex cell culture models;FEMS Microbiology Reviews;2024-02-26

3. HS-GC–MS analysis of volatile organic compounds after hyperoxia-induced oxidative stress: a validation study;Intensive Care Medicine Experimental;2024-02-12

4. Metabolic insights at the finish line: deciphering physiological changes in ultramarathon runners through breath VOC analysis;Journal of Breath Research;2024-02-12

5. Volatilomes of human infection;Analytical and Bioanalytical Chemistry;2023-10-16